Endocrine therapies in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer: A network meta-analysis

BACKGROUND: Recently, many endocrine therapies have become available for hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer. Direct comparisons of these novel treatments to assess their added value, however, are lacking METHODS: Our aim w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Cho-Hao, Kang, Yi-No, Ho, Ching-Liang, Lin, Chin, Chen, Po-Huang, Wu, Yi-Ying, Huang, Tzu-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220437/
https://www.ncbi.nlm.nih.gov/pubmed/32221087
http://dx.doi.org/10.1097/MD.0000000000019618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220437/
https://www.ncbi.nlm.nih.gov/pubmed/32221087
http://dx.doi.org/10.1097/MD.0000000000019618

Ejemplares similares